Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
CATALIST-LISTED healthcare company QT Vascular has announced that it has enrolled the first 11 patients in its First-In-Human (FIH) study of its novel Chocolate Touch PTCA (Coronary Drug Coated Chocolate) in the Dominican Republic.
In a filing to the Singapore Exchange on